0001562180-24-002476.txt : 20240308 0001562180-24-002476.hdr.sgml : 20240308 20240308161643 ACCESSION NUMBER: 0001562180-24-002476 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hardy Nathan CENTRAL INDEX KEY: 0001830053 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 24734578 MAIL ADDRESS: STREET 1: C/O SANA BIOTECHNOLOGY, INC. STREET 2: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-03-07 false 0001770121 Sana Biotechnology, Inc. SANA 0001830053 Hardy Nathan C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false EVP, Chief Financial Officer false Restricted Stock Units 2024-03-07 4 A false 67083.00 0.00 A Common Stock 67083.00 67083.00 D Stock Option (Right to Buy) 9.58 2024-03-07 4 A false 301875.00 0.00 A 2034-03-06 Common Stock 301875.00 301875.00 D Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock. The restricted stock units vest in four equal installments on each of March 7, 2025, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. The option vests and becomes exercisable as to 25% of the underlying shares on March 7, 2025 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. /s/ Julie Shah, Attorney-in-Fact for Nathan Hardy 2024-03-08